Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )

Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib

Dr Tony Mok - Chinese University of Hong Kong

Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )

Sorafenib does not extend overall survival as third or fourth line therapy in...

Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain

Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial ( Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain )

Tobacco control and prevention through social media

Joan Bottorff – University of British Columbia, Kelowna, Canada

Tobacco control and prevention through social media ( Joan Bottorff – University of British Columbia, Kelowna, Canada )

Cancer prevention and epidemiology in Russia

Dr David Zardize – Russian National Cancer Research Centre, Moscow, Russia

Cancer prevention and epidemiology in Russia ( Dr David Zardize – Russian National Cancer Research Centre, Moscow, Russia )

Importance of cancer prevention

Prof Murat Tuncer - Hacettepe University, Ankara, Turkey

Importance of cancer prevention ( Prof Murat Tuncer - Hacettepe University, Ankara, Turkey )

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain

Epigenetics of cancer and changes in DNA modification in tumours ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain )

Drug development in small cell and non-small cell lung cancer

Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA

Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Afatinib delays progression of advanced lung adenocarcinomas

Dr James Yang - National Taiwan University Hospital, Taipei

Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )

Routine molecular testing of non-small cell lung cancers in community settings

Dr Thomas Zander - University Hospital Cologne, Germany

Routine molecular testing of non-small cell lung cancers in community settings ( Dr Thomas Zander - University Hospital Cologne, Germany )

Increased progression-free survival in advanced lung cancer with afatinib

Dr James Yang - National Taiwan University Hospital Taipei, Taiwan

Increased progression-free survival in advanced lung cancer with afatinib ( Dr James Yang - National Taiwan University Hospital Taipei, Taiwan )

Early results from new PD-1 targeted immune therapy

Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore...

Early results from new PD-1 targeted immune therapy ( Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore, USA )

More from ecancer